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Background & aims: The rate of mortality from Spontaneous Peritonitis (SP) in cirrhotic patients is still
high despite the development of new antibiotic treatments and intensive hospital care. The coexistence
of spontaneous fungal peritonitis (SFP) is almost entirely ignored health problem, because it is difficult to
be diagnosed at an early stage by conventional culture-based methods. Therefore, this study was
designed to employ PCR-based method in evaluating the prevalence of fungal infection in cirrhotic
patients with peritonitis who failed to respond to the recommended therapy and to determine its asso-
ciation with in-hospital mortality.
Subjects and Methods: A total of 80 cirrhotic patients admitted to the hospital with ascitis (June-2013 to
April-2015) were followed in this study.
Results: During hospitalization, 23 (42%) of patients had died although they received guideline-driven
treatment. The demographics, clinical, hematological, and biochemical data were similar in both mortal-
ity and survival groups. However, the incidence of fungus infection was the only significantly elevated
parameter in the mortality group than in the survival group (7/23;30% vs.0/32;0%, P = 0.0012). This fungal
infection was significantly associated with SP drug resistance development (P = 0.007). Intriguingly, all
the cases of fungal infection were detected by PCR-based method while culture-based diagnosis was able
to detect the fungal infection in only 4 of these cases indicating a diagnostic sensitivity of 57%.
Conclusion: Our results reflect a strong association between SFP and in-hospital mortality in cirrhotic
patients with SP that may offer a coherent explanation for the antibiotic treatment failure in such
patients. Prompt PCR-detection and antifungal coverage is warranted in these cases.
 2016 Production and hosting by Elsevier B.V. on behalf of Mansoura University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Spontaneous Peritonitis (SP) is one of the most deadly life
threatening complications of liver cirrhosis [1]. The key pathogenic
mechanism initiating SP is the translocation of enteric pathogens,
such as gram-negative bacteria, endotoxin, gram-positive bacteria,
and fungi from the gut to peritoneal fluid. In cirrhosis, the rate ofsuch pathogenic translocation increases due to the compromise
of intestinal epithelial barrier integrity as well as immune surveil-
lance mechanisms [2]. Early diagnosis and effective treatment of SP
is essential to shorten hospital stays and reduce mortality. The
diagnosis is established by ascitic fluid polymorphonuclear
(PMN) count >250 cells/mm3 [3]. Additionally, ascitic fluid is rou-
tinely cultured in blood culture bottles to identify the pathogen.
The most frequently isolated microorganisms are gram-negative
bacilli [4]. Therefore, existing clinical guidelines of the Interna-
tional Ascites Club, the American Association for the Study of Liver
Diseases, and the European Association for the Study of the Liver
recommend third-generation cephalosporins as an empirical ther-
apy for SP [5,6]. For acute SP, intravenous cefotaxime (2 gm/12 h
for 5 days) is usually used, while prophylactic therapy entails nor-
floxacin (400 mg/day) [7]. Nevertheless, the rate of SP mortality is
still high ranges from 40% to 70% despite the early diagnosis,aneous
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care [8].
It is widely accepted that resistance to third-generation cepha-
losporins is the prevailing cause of mortality among all SP cases.
This is evident from the high mortality rate among cirrhotic
patients with infection by germs resistant to third-generation
cephalosporins in comparison to those infected by pathogens that
are sensitive to antimicrobials [9]. Third-generation
cephalosporin-resistant SP is a common diagnosis when antibiotic
treatment fails to drop the PMN count by at least 25% during 48 h
[5]. Several mechanisms have been proposed regarding how antibi-
otic resistance occurs in SP. One such mechanism refers to the
increased incidence of extended-spectrum-b-lactamase (ESBL)
producing enterobacteriaceae, causing resistance to third-
generation cephalosporins [10]. The other reported mechanism
results in treatment failure with antibacterial agents in SP is the
existence of fungal infection [11]. Candida albicansis is the most
commonly detected fungus from ascitic fluid of cirrhotic patients
and has been reported as potent etiological agents of SP. However,
spontaneous fungal peritonitis (SFP) does not differ symptomati-
cally from spontaneous bacterial peritonitis (SBP). Furthermore,
SFP is difficult to be diagnosed at an early stage by conventional
culture-based methods due to the longer time spent on fungal cul-
ture results and usually passed unnoticed. Because of these limita-
tions, incidence of SFP was reported as rare with ill-defined clinical
characteristics and prognosis [12].
These clinical difficulties impose the necessity of accurately
detecting SFP at the earliest stage possible before the start of
guideline-driven treatments. Recent diagnostic advances, includ-
ing detection of fungal cell wall components such as galactoman-
nan and B-glucan, or detection of fungal genomic DNA by
polymerase chain reaction (PCR), would improve diagnostic ability
and increase clinical awareness for SFP [13]. So far, studies evalu-
ating the usefulness of these molecular techniques in the diagnosis
of SFP in cirrhotic patients are scarce, especially from our region.
Thus, the current study was undertaken to use DNA-based
PCR method in evaluating the prevalence of fungal infection in cir-
rhotic patients with peritonitis who failed to respond to the recom-
mended antibiotic therapy. Furthermore, the present work aimed
to gain new insights into the clinical characteristics and prognosis
of SFP in comparison with other groups of cirrhotic patients with
non-fungal peritonitis.2. Patients and methods
2.1. Population for analysis
The current investigation is a prospective case-control based
study, which was approved by the ethical institutional review
board at Mansoura University that complies with acceptable inter-
national standards. Written informed consent for participation was
obtained from each participant. From June 2013 through April
2015, 80 case patients were recruited from the population of
patients with diagnosed liver cirrhosis who were evaluated and
treated at intensive care unit of hepatology and gastroenterology
department in Mansoura University Hospital (MUH). The inclusion
criteria were the presence of ascites with pathologically and ultra-
sonography confirmed liver cirrhosis and Egyptian residency. The
severity of liver cirrhosis was assessed according to the Child–Pugh
classification. The exclusion criteria were the presence of intra-
abdominal surgery and secondary peritonitis. At the study entry,
a thorough medical history was taken, physical examination was
performed, and in-hospital mortality was assessed. The flowchart
of the included cases is in Fig. 1.Please cite this article in press as: Elkhateeb SR et al. PCR-detected fungal infecti
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Blood and ascitic fluid samples were collected from each
patient. The blood sample (5 mL) was used for complete blood pic-
ture and serum separation. Serum samples were assayed for liver
function markers; albumin, bilirubin, alanine aminotransferase
(ALT) and aspartate aminotransferase (AST). Additionally, crea-
tinine, random blood glucose, sodium and potassium levels were
determined with commercial available kits.
Ascitic fluid (20 mL) was aspirated under all aseptic condition,
before the initiation of antibiotic therapy. 10 mL of ascitic fluid
was immediately inoculated at bedside into culture bottle while
the other 10 mL was sent for biochemical analysis and PMN count-
ing. For bacteria cultures, ascetic fluid samples were directly cul-
tured and sub-cultured on blood as well as MacConkey agar
plates at 37 C. Identification of bacterial cultures was performed
by gram staining and confirmed by coagulase test for gram positive
cocci. For fungal cultures, ascetic fluid samples were directly cul-
tured and sub cultured on Sabouraud’s dextrose agar (SDA) for
up to 14 days and examined by microscopy to detect fungal infec-
tion. In the biochemical analysis of ascitic fluid total protein con-
tent, albumin level, glucose level, and lactate dehydrogenase
(LDH) activity were determined. The remaining ascitic fluid sam-
ples were used for DNA extraction followed by detection of univer-
sal fungal gene by PCR technique.
2.3. PCR detection of ascitic fungal DNA
Extracted DNA was detected with panfungal PCRs using ITS1
forward primer and ITS4 universal reverse primer, which amplify
the ITS1 regions of fungal rDNA genes. The PCR mixture (25 ll)
included the following: 12.5 ll of Taq PCR Master Mix, 1 ll of each
primer, 2 ll of template DNA, and 8.5 ll nuclease-free water. The
samples were then placed in a thermal cycler (MJ Research, Inc.,
USA) with amplification program as follow: One cycle at 95 C
for 5 min, followed by 30 cycles, each consisting of three steps;
Denaturing step (30 s at 95 C), annealing step (30 s at 55 C),
extension step (45 s at 72 C), followed by one cycle at 72 C for7 -
min as a final step, A reagent blank, which contained all compo-
nents of the reaction mixture with the exception of template
DNA, was included in every PCR procedure. The PCR products were
visualized on a UV transilluminator after electrophoresis on 2%
agarose gels using ethidium bromide at 0.5 lg/ml.
2.4. Statistical analysis
The data collected in this study were processed and statistically
analyzed by using IBM SPSS (Statistical Package for Social Science)
software version 20 (Chicago, IL, U.S.A.). For descriptive statistics,
frequency and percentage were calculated for qualitative variables,
while the mean ± SD, median and range were used for quantitative
variables. Qualitative data were assessed by Chi-Square test. Quan-
titative data were first checked for skewness and an unpaired t-test
was performed if the distribution of the values was Gaussian. If the
distribution was not normal, a non-parametric test, Mann-Whitney
test, was used. P values less than 0.05 were considered to be statis-
tically significant.3. Results
A total of 80 patients were admitted with ascites due to cirrho-
sis during the study period, between 1 June 2013 and 30 April
2015. Of these, there were 55 (68.75%) patients with ascitic fluid
infection (AFI) diagnosed by polymorph nuclear (PMN) count
>250/mm3. These patients were hospitalized, given the standardon is associated with fatal outcomes in cirrhotic patients with spontaneous
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Fig. 1. The flow chart of the included cases. A total of 80 patients were admitted with ascites due to cirrhosis Of these, there were 55 patients with ascitic fluid infection (AFI)
diagnosed by polymorph nuclear (PMN) count >250/mm3. These patients were hospitalized and during hospitalization, 23 of these patients had died although they received
guideline-driven treatment. The incidence of fungus infection was the only significantly elevated parameter in the mortality group than in the survival group (7/23; 30% vs. 0/
32. All cases of fungal infection were detected by PCR-based method while culture-based diagnosis was able to detect the fungal infection in only4 of these cases.
Table 1
Demographic and clinical presentation of patients within survival and mortality
groups.
Parameter Survival
group (n = 32)
Mortality
group (n = 23)
P value
Age (years ± SD) 55.78 ± 9.3 58.74 ± 8.8 0.2401
Gender (M/F) 21/11 17/6 0.5668
Abdominal Pain (Y/N) 1/31 1/22 1.00
Jaundice (Y/N) 20/12 16/7 0.7745
Encephalopathy (Y/N) 9/23 7/16 1.00
Diabetes (Y/N) 7/25 4/19 0.7452
Child Paugh Score (b/c) 12/20 3/20 0.0660
Table 2
Hematological, biochemical, and liver function analysis of patients in survival and
mortality groups.
Parameter (mean ± SD) Survival group
(n = 32)
Mortality group
(n = 23)
P
value
Hb (g/dL) 9.84 ± 1.82 9.72 ± 1.52 0.79
RBC counts (106/
mm3 ± SD)
3.34 ± 0.89 3.33 ± 0.73 0.942
WBC counts (103/
mm3 ± SD)
9.84 ± 1.82 9.72 ± 1.51 0.793
Platelet counts (103/
mm3 ± SD)
155.81 ± 134.51 147.48 ± 115.97 0.81
Creatinine (mg/dL) 1.48 ± 0.99 1.88 ± 1.27 0.19
Blood glucose (mg/dL) 173.69 ± 132.09 165.13 ± 100.41 0.80
Sodium (mmol/L) 126.90 ± 8.16 128.04 ± 7.49 0.60
Potassium (mmol/L) 4.13 ± 0.72 4.11 ± 0.72 0.95
ALT (U/ml) 36.03 ± 22.36 36.78 ± 33.17 0.92
AST (U/ml) 70.55 ± 60.07 63.10 ± 55.52 0.64
Albumin (g/dL) 2.34 ± 0.42 2.36 ± 0.47 0.91
Bilirubin (mg/dL) 3.60 ± 2.95 3.70 ± 2.60 0.91
INR 1.55 ± 0.54 1.44 ± 0.28 0.43
Table 3
Biochemical analysis of ascetic fluid of patients in survival and mortality groups.
Parameter Survival group
(n = 32)
Mortality group
(n = 23)
P
value
SAAG (g/dL) 1.56 ± 0.46 1.48 ± 0.45 0.55
Albumin (g/dL) 0.79 ± 0.46 0.88 ± 0.41 0.46
Glucose (mg/dL) 92.83 ± 90.04 110.26 ± 107.53 0.52
Total protein (g/dL) 2.79 ± 1.12 2.69 ± 1.23 0.76
LDH (IU/L) 317.03 ± 420.42 266.05 ± 129.64 0.58
PCR-based Fungal detected
infection (Y/N)
0/32 7/16 0.0012
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analysis. During hospitalization, 23 (42%) of these patients had
died although they received guideline-driven treatment. Therefore,
further analysis was performed to find out factors associated with
in-hospital mortality in AFI. The characteristics and laboratory data
at admission of patients in the mortality and survival groups were
compared. The demographics and clinical data of patients within
both groups are shown in Table 1 and were matched for age, gen-
der, clinical features, and complications such as abdominal pain,
jaundice, encephalopathy diabetes, and Child-Paugh score. Hema-
tological and biochemical laboratory tests including hemoglobin,
red blood cell (RBC) count, white blood cell (WBC) count, platelet
count, creatinine, blood glucose, sodium, and potassium levels
together with liver function tests were similar in the two groups
(Table 2). Furthermore, no differences in the serum ascites albumin
gradient (SAAG) and the ascitic fluid analysis, including its concen-
trations of albumin, glucose, and total protein as well as lactate
dehydrogenase activity, were found between the two groups.
However, the highest incidence of fungus infection was the only
significantly elevated parameter in the mortality group than in
the survival group (7/23; 30% vs. 0/32; 0%, P = 0.0012) (Table 3).
This reflects a strong association between fungal peritonitis and
in-hospital mortality in cirrhotic patients with Spontaneous Peri-
tonitis. Intriguingly, all the cases of fungal infection were detected
by PCR-based method while culture-based diagnosis was able to
detect the fungal infection in only 4 of these cases indicating a
diagnostic sensitivity of 57%.Please cite this article in press as: Elkhateeb SR et al. PCR-detected fungal infecti
peritonitis. Egyp. Jour. Bas. App. Sci. (2016), http://dx.doi.org/10.1016/j.ejbas.2The aforementioned results provide a rationale to specifically
analyze data from patients with spontaneous fungal peritonitis
(SFP) in comparison with other groups with non-fungal AFI. The
majority of included cases (41/55, 74.5%) had culture negative neu-
trocytic ascites (CNNA), characterized by PMN count >250/mm3
and a negative ascitic fluid culture. However, there were 7
(12.72%) patients who had another variant of AFI, characterizedon is associated with fatal outcomes in cirrhotic patients with spontaneous
016.10.002
Table 4
Demographic and clinical presentations of patients with spontaneous fungal
peritonitis (SFP) and those with culture negative neutrocytic ascites (CNNA).
Parameter CNAA group (n = 41) SFP group (n = 7) P value
Age (years ± SD) 55.1 ± 9.48 59.85 ± 9.3 0.4893
Gender (M/F) 27/14 6/1 0.4087
Abdominal Pain (Y/N) 1/40 1/6 0.2730
Jaundice (Y/N) 26/15 4/3 1.0000
Encephalopathy (Y/N) 8/33 3/4 0.3271
Diabetes (Y/N) 8/33 1/6 1.0000
Child Paugh Score (b/c) 14/27 0/7 0.0662
Table 5
Hematological, biochemical, and liver function analysis of patients with spontaneous
fungal peritonitis (SFP) and those with culture negative neutrocytic ascites (CNNA).
Parameter (mean ± SD) CNAA group
(n = 41)
SFP group
(n = 7)
P value
Hb (g/dL) 9.81 ± 1.48 9.19 ± 1.84 0.32
RBC Counts (106/mm3 ± SD) 3.30 ± 0.72 3.28 ± 0.76 0.94
WBC Counts (103/
mm3 ± SD)
8.11 ± 3.73 11.74 ± 6.14 0.04
Platelet Counts (103/
mm3 ± SD)
146.24 ± 120.94 179.86 ± 158.21 0.52
Creatinine (mg/dL) 1.31 ± 0.84 2.43 ± 1.37 0.01
Blood Glucose (mg/dL) 163.24 ± 113.36 205.29 ± 127.18 0.38
Sodium (mmol/L) 128.02 ± 7.48 129.39 ± 5.03 0.65
Potassium (mmol/L) 4.06 ± 0.65 4.08 ± 0.82 0.68
ALT (U/ml) 38.33 ± 26.85 36.57 ± 38.36 0.88
AST (U/ml) 69.23 ± 55.52 66.57 ± 51.21 0.91
Albumin (g/dL) 2.37 ± 0.42 2.49 ± 0.49 0.50
Bilirubin (mg/dL) 5.40 ± 9.16 3.46 ± 3.27 0.58
INR 1.52 ± 0.17 1.30 ± 0.28 0.43
Table 6
Biochemical analysis of ascetic fluid of patients with spontaneous fungal peritonitis
(SFP) and those with culture negative neutrocytic ascites (CNNA).
Parameter CNAA group
(n = 41)
SFP group
(n = 7)
P
value
SAAG (g/dL) 1.52 ± 0.46 1.59 ± 0.52 0.70
Albumin (g/dL) 0.85 ± 0.44 0.89 ± 0.49 0.80
Glucose (mg/dL) 100.29 ± 81.98 142.37 ± 178.97 0.31
Total protein (g/dL) 2.69 ± 1.22 2.98 ± 1.04 0.56
LDH (IU/L) 220.92 ± 208.99 374.29 ± 121.97 0.0026
Resistance to antibiotic (Y/
N)
12/29 7/0 0.0007
4 S.R. Elkhateeb et al. / Egyptian Journal of Basic and Applied Sciences xxx (2016) xxx–xxxby PMN count >250/mm3 and a positive ascitic fluid culture with-
out any evidence of external or intra-abdominal source of infec-
tion. The detected organisms were E. coli (57.14%),
Staphylococcus aureus (28.5%), and Klebsiella (14.2%). Guided by
these results, we proceeded to compare the biochemical and clin-
ical outcomes between patients with SFP and patients with CNAA.
The demographics and clinical data of patients with SFP or
CNNA are shown in Table 4. The two groups were matched for
age, gender, clinical features, and complications such as abdominal
pain, jaundice, encephalopathy and diabetes. According to the
Child–Pugh classification, all SFP patients (100%) were class C
while 27 patients in CNNA (65.9%) were class C. Majority of hema-
tological and biochemical laboratory tests including hemoglobin,
RBC, and platelet counts; blood glucose, sodium, and potassium
levels together with liver function tests were similar in the two
groups. Nevertheless, there were significantly higher level of crea-
tinine and WBC counts in SFP group as compared to CNNA, p-
value = 0.01 and 0.04, respectively (Table 5). Similarly, SFP group
had a high LDH activity as compared to CNNA, P = 0.0026. There
were no statistical differences in the SAAG and the ascitic fluidPlease cite this article in press as: Elkhateeb SR et al. PCR-detected fungal infecti
peritonitis. Egyp. Jour. Bas. App. Sci. (2016), http://dx.doi.org/10.1016/j.ejbas.2analysis, including its concentrations of albumin, glucose, and total
protein, were found between the two groups (Table 6).
Next we sought to delineate factors underlying the increased
in-hospital mortality in patients with fungal peritonitis by investi-
gating its association with the development of treatment failure.
Treatment failure was defined as a <25% decrease in ascitic fluid
PMN in follow-up paracentesis and persistence of signs of infec-
tion. As shown in Table 6, the fungal infection was significantly
associated with SP drug resistance development (P = 0.007). Taken
together, our results suggested that fungal peritonitis is a potential
factor associated with substantially increased in-hospital mortality
rate in cirrhotic patients with peritonitis due to the development of
resistance to the standard regimen therapy that is characterized
biochemically by increased creatinine level and increased LDH
activity.4. Discussion
Spontaneous Peritonitis (SP) is an important cause of morbidity
and mortality in cirrhotic patients with ascites due to antibiotic
treatment failure. There are multiple etiological factors affecting
the response of SP to therapy, all of which vary by geographical
location and have a direct impact on the characteristics of these
patients, making SP an extremely complex condition [14]. The
worldwide spread of extended-spectrum-b-lactamase (ESBL) pro-
ducing enterobacteriaceae is the major culprit risk factor recog-
nized for antibiotic treatment failure in SP [15]. Nonetheless, in
10–30% of patients with antibiotic-resistant SP, no defined cause
is found. Therefore, it is conceivable that risk factors other than
ESBL-producing bacteria exist for antibiotic treatment failure in
SP, but the evidence is still unclear. The co-existence of fungal
infection is usually an overlooked health problem that naively
belittled in advanced medical care due to its difficulty to be diag-
nosed at an early stage by conventional culture-based methods.
In this study, we put forward a new concept pertaining to the pos-
sible association of fungal infection with the development of treat-
ment failure and subsequent mortality among cirrhotic patients
with SP. Furthermore our study demonstrates a heretofore unre-
ported utility of amplifying ITS1/rDNA by PCR as a sensitive and
rapid method for diagnosing fungal infection in ascitic fluids from
cirrhotic patients with SP.
Fungal infection and its toxin are well known in developing
countries, such as Egypt, and have been implicated in a wide num-
bers of acute and chronic human diseases, including liver cancer
and nephropathy [16,17]. However, the incidence of spontaneous
fungal peritonitis (SFP) has been considered to be infrequent in cir-
rhotic patients and it is not well described [18]. This is due to the
lack of clinical awareness for SFP, absence of the characteristic
symptoms, and longer time spent on fungal culture to diagnose
SFP [19]. It is therefore essential to use rapid and accurate non-
culture-based methods for the detection of SFP. The ribosomal
DNA (rDNA) is highly conserved in all fungal species, thus provid-
ing unquestionable information on the identification of fungal
infection in body fluids and being an indicator of continuous expo-
sure to such infection [20]. Accordingly, in the current work, the
prevalence of fungal infection in our patients was evaluated with
the help of this biomarker, which was amplified by PCR reaction
using pan primer (IT1). The use of panfungal PCR in the detection
of systemic fungal infection has been established previously and
provides potential in terms of sensitivity and specificity. This input
has originated partly from studies on whole-blood specimens from
patients infected with fungi that showed panfungal PCR assay can
detect multiple fungal genera [21]. These initial observations have
been supported by showing the usefulness of Panfungal PCR for the
diagnosis of fungal infection in neutropenic cancer patients [22],on is associated with fatal outcomes in cirrhotic patients with spontaneous
016.10.002
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[24], and in those with end-stage liver disease [19]. In concordance
with these previous studies, our results demonstrate the superior-
ity of Panfungal PCR over the conventional culture-based methods
for the detection of fungal infection. However, our study is the first
to report the potential utility of Panfungal PCR in detecting fungal
infection in ascitic fluids from cirrhotic patients with SP. In our
hospital, fungal peritonitis was detected in 12.3% of cirrhotic
patients with SP with an incidence comparable to that of SBP char-
acterized by PMN count >250/mm3 and a positive ascitic fluid cul-
ture. Our results are in reasonable agreement with those of Hassan
et al., who have shown the prevalence of SFP in Egyptian patients
with end-stage liver disease to be 8.6%. This implies that fungi are
not very rare causes of SP in our region which is almost 4 times
higher compared to what has been reported in Republic of Korea
(3.6%) [12]. This discrepancy may be explained not only by the dif-
ference in geographic location and in socio-demographic charac-
teristics of the study groups, but also by the use of different
method for detecting SFP.
Comparing the biochemical and clinical outcomes between SP
cirrhotic patients with or without fungal infection, we found that
patients with fungal infection had higher Child–Pugh score,
increased creatinine level, and increased LDH activity and all died
of the disease during hospitalization. Development of resistance to
the standard regimen therapy may explain why SFP had a worse
prognosis and a higher mortality compared with those with non
fungal SP. Several mechanisms have been proposed regarding
how fungal infection confers bacterial resistance to antibiotic ther-
apy that can be applied to antibiotic-resistant SP seen in our cir-
rhotic patients. One such mechanism refers to the bacterial
fungal interaction and the formation of a highly structured, often
surface-associated, communities termed biofilms [11]. The forma-
tion of mixed-species biofilm creates a protected environment that
promotes the resistance to both host clearance pathways and
antimicrobial agents as well [25]. The extend of protection depends
on the relative level of matrix polymers produced by both organ-
isms within the biofilm. The more viscous matrix produced, the
more effective it is in restricting the penetration of drugs [26].
Besides bacterial fungal biofilms, other reported effects might have
contributed to the acquired bacterial antibiotic resistance in SP,
such as interspecies communication [25], and changes in microbial
behavior and survival that occur when bacteria and fungi occupy
the same sites [11].
Collectively, our study identified fungal infection as a potential
risk factor associated with increased in-hospital mortality in cir-
rhotic patients with SP pathogenesis. Our patients with fungal
peritonitis were resistant to the standard regimen, had a worse
prognosis characterized by higher Child–Pugh score, increased cre-
atinine level, increased LDH activity, and higher mortality com-
pared with those with non fungal SP. Considering these data, we
envision the future clinical amalgamation of PCR-based fungal
detection as well as antifungal coverage with existing guidelines
for treating cirrhotic patients with antibiotic-resistant SP.Conflict of interest
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